DeviceClearance

MODIFICATION TO CHAD THERAPEUTICS OXYMATIC MODEL 401— 510(k) K003455

Substantially Equivalent

Chad Therapeutics, Inc.

FDA 510(k) clearance K003455 for MODIFICATION TO CHAD THERAPEUTICS OXYMATIC MODEL 401, Substantially Equivalent on 2000-12-06. Applicant: Chad Therapeutics, Inc..

Clearance details

Applicant
Chad Therapeutics, Inc.
Product code
Code NFB
Advisory panel
Anesthesiology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
Chatsworth, CA, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.